RIVM investigates dangers of e-cigarette At the request of State Secretary Martin van Rijn (VWS), RIVM is carrying out an investigation into the safety of e-cigarettes.
The National Immunisation Programme in the Netherlands: Developments in 2013 Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).
Cervical cancer screening in the Netherlands January 19 - 25 European Cervical Cancer Prevention Week.
Further research into hazards posed by e-cigarettes Safety of nicotine-containing electronic cigarettes (e-cigarettes) cannot be confirmed because of the limited amount of published research in this area.
Is screening for sexually transmitted infections as part of HIV care cost-effective in the Netherlands? Routine screening for anorectal chlamydia among HIV-positive men who have sex with men (MSM) could avert further spread of chlamydia and HIV in the total MSM population.
Regional differences in testing rates underestimate incidence of LGV epidemic Until 2003, Lymphogranuloma venereum (LGV), an aggressive form of chlamydia, was considered to be a rare tropical disease, endemic to Africa, Asia and the Caribbean.
Fewer municipalities with low vaccination coverage In the Netherlands, there are 80 municipalities with a low vaccination coverage for one or more vaccinations. This is a decrease compared to last year when there were still 90 municipalities.
More people visiting STI clinics in 2012 with chlamydia and gonorrhea infections In 2012, the number of new consultations at Sexually Transmitted Infections (STI) clinics in the Netherlands increased by 7% over the previous year.
ICP M&M meetings in 2013 The 23rd CCE Workshop and 29th Task Force Meeting of the ICP M&M will be held 8-11 April 2013 in Copenhagen, Denmark.
Call for data on "no net loss of biodiversity" The CCE is pleased to publicate an announcement and a detailed substantiation and technical description of the call for data on “no net loss of biodiversity” which has been adopted at the 31st meet